Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:26:12.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision metadata updated to add v3.4.2 and remove v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:33:30.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:52:17.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Show glossary option and new metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T07:26:21.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 added and Revision: v3.3.3 removed are administrative/versioning updates and do not modify study content. - There is no impact on the study details, eligibility criteria, outcomes, or other core information. - To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:47:42.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Locations section updated; Maryland, North Carolina, and Pennsylvania sites added and the HHS Vulnerability Disclosure link removed as part of revision 3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T21:20:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.